A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration

Journal of Clinical Pharmacology

Volumn 40, Issue 7, 2000, Pages 770-780

  Argenti, D ^a   Jensen, B K ^a   Hensel, R ^a   Bordeaux, K ^a   Schleimer, R ^b   Bickel, C ^b   Heald, D ^a  

^a Drug Safety and Metabolism   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 CARBOXYLIC ACID TRIAMCINOLONE ACETONIDE; 6BETA HYDROXY 21 OIC TRIAMCINOLONE ACETONIDE; 6BETA HYDROXY TRIAMCINOLONE; CARBON 14; DRUG METABOLITE; GLUCOCORTICOID; INTERLEUKIN 5; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BASOPHIL; CELL VIABILITY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG TRANSFORMATION; EOSINOPHIL; HISTAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; RADIOACTIVITY;

EID: 0033637011     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700022009413     Document Type: Article

References (29)

1. New perspectives on inhaled drug delivery and systemic bioactivity
2. Aerosol deposition in man
3. Airway and systemic effects of inhaled corticosteroids in asthma: Dose response relationships
4. A rapid Percoll technique for the purification of basophils
5. Basophil counting with a new staining method using Alcian blue
6. Inhibition of basophil histamine release by anti-inflammatory steroids
7. An automated continuos-flow system for the extraction and fluorometric analysis of histamine
8. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils
9. A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation administration
10. Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration
11. Inhaled corticosteroids in asthma: A dose-proportionality study with triamcinolone acetonide aerosol
12. Issues in the use of inhaled glucocorticoids
13. Flunisolide metabolism and dynamics of a metabolite
14. Absorption and metabolism of orally administered beclomethasone dipropionate
15. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid
16. The human pharmacology of fluticasone propionate
17. The metabolic fate of triamcinolone acetonide in laboratory animals
18. 14C: A comparative study
19. Methyl-prednisolone versus prednisolone pharmacokinetics in relation to dose in adults
20. Glucocorticoid pharmacokinetics
21. Metabolic pathways of the topical glucocorticoid budesonide in man
22. Liver metabolism of budesonide in rat, mouse, and man
23. Metabolic fate of beclomethasone 17, 21 dipropionate
24. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma
25. Inhibition of basophil histamine release by anti-inflammatory steroids: II. Studies on the mechanism of action
26. Inhibition of inflammatory cell recruitment by glucocorticoids: Cytokines as primary targets
27. Human endothelial cells prolong eosinophil survival: Regulation by cytokines and glucocorticoids
28. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16α, 17α-acetal substituted glucocorticoids